Analyst Price Targets — AVNS
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| October 30, 2024 3:10 pm | Rick Wise | Stifel Nicolaus | $20.00 | $18.58 | StreetInsider | Avanos Medical (AVNS) PT Lowered to $20 at Stifel |
| January 6, 2023 8:50 am | — | Morgan Stanley | $26.00 | $26.99 | Benzinga | Morgan Stanley Maintains Underweight on Avanos Medical, Raises Price Target to $26 |
| July 18, 2022 9:35 am | — | Stifel Nicolaus | $28.00 | $26.89 | Benzinga | Stifel Maintains Hold on Avanos Medical, Lowers Price Target to $28 |
| July 15, 2022 9:38 am | — | Morgan Stanley | $28.00 | $27.19 | Benzinga | Morgan Stanley Maintains Underweight on Avanos Medical, Lowers Price Target to $28 |
| May 5, 2022 7:56 am | — | Morgan Stanley | $33.00 | $29.29 | Benzinga | Morgan Stanley Maintains Underweight on Avanos Medical, Lowers Price Target to $33 |
This site can’t be displayed in an embedded view
Some publishers block loading inside other sites for security reasons. You can open the article in a new tab instead.
Latest News for AVNS

ALPHARETTA, Ga. and NEW YORK, July 2, 2026 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) ("Avanos") and American Industrial Partners ("AIP") jointly announced the receipt of all required regulatory approvals to complete the pending acquisition of Avanos by affiliates of investment funds advised by AIP (the "Merger").

Are CRBG, EQH, AVNS Obtaining Fair Deals for their Shareholders? PR Newswire NEW YORK, June 25, 2026

Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of [url="]Kahn Swick and Foti[/url], LLC (âKSFâ) are investigating the propos

NEW YORK & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Avanos Medical, Inc. (NYSE: AVNS) to affiliates of American Industrial Partners. Under the terms of the proposed transaction, shareholders of Avanos will receive $25.00 in cash for each share of Avanos that they own. KSF is…

AVNS' SNS momentum, Nexus Medical integration and AIP deal support growth, but tariff costs, margin pressure and PM&R weakness remain headwinds.
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for AVNS.
U.S. House Trading
House Trades Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
Options Chain Settings
Changes apply instantly as you toggle. Tap Done when finished.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.
